TREA

78524381 - MEPACT

Follow

Information

  • Trademark
  • 78524381
  • Serial Number
    78524381
  • Registration Number
    3116184
  • Filing Date
    November 30, 2004
    20 years ago
  • Registration Date
    July 18, 2006
    18 years ago
  • Transaction Date
    April 02, 2013
    11 years ago
  • Status Date
    February 22, 2013
    11 years ago
  • Published for Opposition Date
    April 25, 2006
    18 years ago
  • Location Date
    July 18, 2006
    18 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FRYE, KIMBERLY
  • Attorney Name
    Dennis A. Bennett
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
MEPACT
Case File Statements
  • GS0011: Chemicals for use in the manufacture of preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-g lycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy
  • GS0051: Preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl- D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-qlycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, and pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations for anti-cancer and antiviral therapies, neoplasia, and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy
Case File Event Statements
  • 2/22/2013 - 11 years ago
    22 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 12/3/2010 - 14 years ago
    21 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 9/1/2010 - 14 years ago
    20 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 10/16/2009 - 15 years ago
    19 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 10/16/2009 - 15 years ago
    18 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 5/1/2008 - 16 years ago
    17 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/16/2008 - 16 years ago
    16 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/18/2006 - 18 years ago
    15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/25/2006 - 18 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/5/2006 - 18 years ago
    13 - NOTICE OF PUBLICATION Type: NPUB
  • 3/2/2006 - 18 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/1/2006 - 18 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 2/8/2006 - 18 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/20/2006 - 18 years ago
    9 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 1/4/2006 - 18 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/4/2006 - 18 years ago
    7 - PAPER RECEIVED Type: MAIL
  • 7/6/2005 - 19 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/6/2005 - 19 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/3/2005 - 19 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/30/2004 - 20 years ago
    3 - APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED Type: AMPX
  • 12/30/2004 - 20 years ago
    2 - PAPER RECEIVED Type: MAIL
  • 12/8/2004 - 20 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP